Mandatory information

mandatory information Bromelain-POS®

500 FIP units, gastro-resistant tablets.
 Active ingredient: bromelain.
 Therapeutic indications: supportive treatment of post-operative and post-traumatic swelling, particularly that of the nose and sinuses. For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. : January 2021
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.

View all madatory information